Daiwa Securities Group’s Pliant Therapeutics PLRX Stock Holding History

Daiwa Securities Group’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-196	Closed	–	–	1422
2025 Q3	$0	Hold	196	–	–	﹤0.01%	1369
2025 Q2	$0	Hold	196	–	–	﹤0.01%	1332
2025 Q1	$0	Hold	196	–	–	﹤0.01%	1312
2024 Q4	$3K	Hold	196	–	–	﹤0.01%	1201
2024 Q3	$2K	Hold	196	–	–	﹤0.01%	1225
2024 Q2	$2K	Hold	196	–	–	﹤0.01%	1259
2024 Q1	$3K	Hold	196	–	–	﹤0.01%	1245
2023 Q4	$4K	Hold	196	–	–	﹤0.01%	1229
2023 Q3	$3K	Hold	196	–	–	﹤0.01%	1201
2023 Q2	$4K	Hold	196	–	–	﹤0.01%	1202
2023 Q1	$5K	Hold	196	–	–	﹤0.01%	1156
2022 Q4	$4K	Buy	196 +73	+59%	+$1.53K	﹤0.01%	1170
2022 Q3	$3K	Hold	123	–	–	﹤0.01%	1201
2022 Q2	$1K	Hold	123	–	–	﹤0.01%	1313
2022 Q1	$1K	Hold	123	–	–	﹤0.01%	1328
2021 Q4	$2K	Hold	123	–	–	﹤0.01%	1295
2021 Q3	$2K	Buy	123 +56	+84%	+$1.19K	﹤0.01%	1246
2021 Q2	$2K	Hold	67	–	–	﹤0.01%	1150
2021 Q1	$3K	Hold	67	–	–	﹤0.01%	1114
2020 Q4	$2K	Buy	+67	New	+$1.68K	﹤0.01%	1132

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Daiwa Securities Group's PLRX Position: Q4 2025 in Review

Daiwa Securities Group sold out of Pliant Therapeutics (PLRX) in Q4 2025, closing a stake of 196 shares.

Daiwa Securities Group first reported a position in PLRX in Q4 2020 and held it in 20 quarters. The position peaked at $5K in Q1 2023. 96 funds tracked by Wall St. Rank hold PLRX as of Q4 2025.

Daiwa Securities Group reported no remaining Pliant Therapeutics position as of Q4 2025 after selling out during the quarter.
Daiwa Securities Group sold 196 Pliant Therapeutics shares in Q4 2025.
Daiwa Securities Group first reported a position in Pliant Therapeutics in Q4 2020 and held it in 20 quarters.
Daiwa Securities Group's Pliant Therapeutics position peaked at $5K in Q1 2023.
96 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2025.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.